Armodafinil in Binge Eating Disorder

Trial Profile

Armodafinil in Binge Eating Disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 18 May 2015

At a glance

  • Drugs Armodafinil (Primary)
  • Indications Binge-Eating Disorder
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 13 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 09 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 Sep 2014 Planned End Date changed from 1 Jun 2014 to 14 Oct 2014 reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top